References
- MalhiHGoresGJCholangiocarcinoma: modern advances in understanding a deadly old diseaseJ Hepatol200645685686717030071
- PatelTCholangiocarcinoma–controversies and challengesNat Rev Gastroenterol Hepatol20118418920021460876
- RazumilavaNGoresGJCholangiocarcinomaLancet201438399352168217924581682
- SahaSKZhuAXFuchsCSBrooksGAForty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the riseOncologist201621559459927000463
- RiberoDPinnaADGuglielmiASurgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patientsArch Surg2012147121107111322910846
- AkamatsuNSugawaraYHashimotoDSurgical strategy for bile duct cancer: advances and current limitationsWorld J Clin Oncol2011229410721603318
- RuzzenenteAConciSValdegamberiAPedrazzaniCGuglielmiARole of surgery in the treatment of intrahepatic cholangiocarcinomaEur Rev Med Pharmacol Sci201519152892290026241545
- CarrafielloGLaganàDCottaERadiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experienceCardiovasc Intervent Radiol201033483583920411389
- KieferMVAlbertMMcNallyMChemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center studyCancer201111771498150521425151
- RafiSPiduruSMEl-RayesBYttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety studyCardiovasc Intervent Radiol201336244044822956045
- HorganAMAmirEWalterTKnoxJJAdjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysisJ Clin Oncol201230161934194022529261
- KimTHHanSSParkSJRole of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancerInt J Radiat Oncol Biol Phys2011815e853e85921497455
- RubinoCde VathaireFDottoriniMESecond primary malignancies in thyroid cancer patientsBr J Cancer20038991638164414583762
- ShahBKBudhathokiNSecond Primary malignancy in Anal carcinoma – a US population-based studyAnticancer Res20153574131413426124366
- RaymondJSHogueCJMultiple primary tumours in women following breast cancer, 1973-2000Br J Cancer200694111745175016721370
- ShahBKKandelPKhanalASecond primary malignancies in hepatocellular cancer - A US Population-based StudyAnticancer Res20163673511351427354616
- DavisEJBeebe-DimmerJLYeeCLCooneyKARisk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort studyCancer2014120172735274124842808
- BlechaczBCholangiocarcinoma: current knowledge and new developmentsGut Liver2017111132627928095
- National Cancer Institute Surveillance, Epidemiology, and End Results Program [homepage on the Internet]SEER program research data 1973–2013 National Cancer Institute DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016 based on the November 2015 submission Available from: http://www.seercancerAccessed August 15, 2016
- Cowens-AlvaradoRSharpeKPratt-ChapmanMAdvancing survivorship care through the National Cancer survivorship Resource Center: developing American Cancer Society guidelines for primary care providersCA Cancer J Clin201363314715023512728
- DinSWongKMuellerMFMutational analysis identifies therapeutic biomarkers in inflammatory bowel disease-associated colorectal cancersClin Cancer Res201824205133514229950348
- HuaiJPDingJYeXHChenYPInflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studiesAsian Pac J Cancer Prev20141583477348224870743
- CarterJHCottrellCEMcNultySNFGFR2 amplification in colorec-tal adenocarcinomaCold Spring Harb Mol Case Stud201736a00149528835367
- AraiYTotokiYHosodaFFibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholan-giocarcinomaHepatology20145941427143424122810
- KimHJYooTWParkDIGene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochem-istry: its prognostic implication in node-positive patientsAnn Oncol200718589289717322545
- LiGZhengJXuBLingJQiuWWangYSimvastatin inhibits tumor angiogenesis in HER2-overexpressing human colorectal cancerBiomed Pharmacother20178541842427887848
- ChowdhryAKFungCChowdhryVKA population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphomaLeuk Lymphoma20185951180118728862484
- MoraisSAntunesLBentoMJLunetNRisk of second primary cancers among patients with a first primary gastric cancer: a population-based study in North PortugalCancer Epidemiol201750Pt A859128843176
- Abdel-RahmanORisk of subsequent primary kidney cancer after another malignancy: a population-based studyClin Genitourin Cancer2017155e747e75428314541
- BezakETakamRYeohEMarcuLGThe risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapyPhys Med20174225325828302493
- NettoreICColaoAMacchiaPENutritional and environmental factors in thyroid carcinogenesisInt J Environ Res Public Health2018158 E1735:1735
- LiuBHervéJBioulac-SagePSodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinomaGastroenterology200713241495150317408651
- MancinoAMancinoMGGlaserSSEstrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factorDig Liver Dis200941215616318395502
- DongLLuJZhaoBWangWZhaoYReview of the possible association between thyroid and breast carcinomaWorld J Surg Oncol201816113029976206
- LiJSHanTJJingNObesity and the risk of cholangiocarcinoma: a meta-analysisTumour Biol20143576831683824729126
- CoyteAMorrisonDSMcLoonePSecond primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry studyBMC Cancer20141427224742063
- FilaliKHédelinGSchafferPMultiple primary cancers and estimation of the incidence rates and trendsEur J Cancer199632A46836908695273
- WeirHKJohnsonCJWardKCColemanMPThe effect of multiple primary rules on cancer incidence rates and trendsCancer Causes Control201627337739026809509
- National Cancer Institute Surveillance, Epidemiology, and End Results Program [homepage on the Internet]Multiple primary and histology coding rulesNIH2007 [updated August 24, 2012 Available from: http://seer.cancer.gov/tools/mphrules/Accessed April 9, 2015
- MurakamiYUemuraKSudoTPrognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinomaAnn Surg Oncol201118365165820945107